Effectiveness and Safety of Transcatheter Patent Foramen Ovale Closure for Migraine

NCT02127294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 258

Last updated 2016-01-13

No results posted yet for this study

Summary

The purpose of the study is to evaluate effectiveness and safety of transcatheter patent foramen ovale closure for migraine.

Conditions

Interventions

DEVICE

transcatheter patent foreman ovale closure

Sponsors & Collaborators

  • Yi Yang

    lead OTHER

Principal Investigators

  • Yi Yang, MD, PhD · The First Hospital of Jilin University

  • Yingqi Xing, MD, PhD · The First Hospital of Jilin University

  • Yuzhu Guo · The First Hospital of Jilin University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-06-30
Completion
2016-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02127294 on ClinicalTrials.gov